Dasatinib for Synovial Sarcoma?

General Blog
1

Here is a new study from Germany suggesting dasatinib as a promising drug for synovial sarcoma:

http://cancerres.aacrjournals.org/content/early/2013/02/22/0008-5472.CAN-12-3023.abstract

MSKCC has an open trial of this drug in combination with ipilimumab:

http://clinicaltrials.gov/ct2/show/NCT01643278